Bank of America
XRTX

Bank of America’s XORTX Therapeutics XRTX Stock Holding History

Bank of America’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$1 – 8252
2023
Q3 		– Hold
0
– – – 7742
2023
Q2 		– Hold
0
– – – 7666
2023
Q1 		– Hold
0
– – – 7734
2022
Q4 		– Sell
-1
Closed -$355 – 8165
2022
Q3 		$0 Buy
+1
New +$563 ﹤0.01% 8238
2022
Q2 		– Hold
0
– – – 8439
2022
Q1 		– Hold
0
– – – 8828
2021
Q4 		– Hold
0
– – – 8692

Other funds holding XRTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

Bank of America's XRTX Position: Q4 2023 in Review

Bank of America held its XORTX Therapeutics (XRTX) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8252.

Bank of America first reported a position in XRTX in Q3 2022 and has held it in 1 quarter since. The position peaked at $0 in Q3 2022. 4 funds tracked by Wall St. Rank hold XRTX as of Q4 2023.

  • Bank of America held 0 shares of XORTX Therapeutics worth $0 as of Q4 2023.
  • Bank of America left its XORTX Therapeutics share count unchanged in Q4 2023.
  • XORTX Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q4 2023, its #8252 holding.
  • Bank of America first reported a position in XORTX Therapeutics in Q3 2022 and has held it in 1 quarter since.
  • Bank of America's XORTX Therapeutics position peaked at $0 in Q3 2022.
  • 4 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.